Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $5.20MP/E –Yield –
Processa Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Processa Pharmaceuticals's cash was $180.21M at Sep 30, 2026. For fiscal 2025 it was $5.54M, up 364.8% from the year before. Over ten years it grew 119.9% a year on average. The highest annual figure on record is $16.50M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.54M | +364.8% |
| FY2024 | Dec 31, 2024 | $1.19M | -74.7% |
| FY2023 | Dec 31, 2023 | $4.71M | -27.6% |
| FY2022 | Dec 31, 2022 | $6.50M | -60.6% |
| FY2021 | Dec 31, 2021 | $16.50M | +7.0% |
| FY2020 | Dec 31, 2020 | $15.42M | +2129.3% |
| FY2019 | Dec 31, 2019 | $691.54K | -60.3% |
| FY2018 | Dec 31, 2018 | $1.74M | -38.9% |
| FY2017 | Dec 31, 2017 | $2.85M | +165.6% |
| FY2016 | Dec 31, 2016 | $1.07M | +51186.8% |
| FY2015 | Dec 31, 2015 | $2.09K | -90.2% |
| FY2014 | Dec 31, 2014 | $21.23K | -88.6% |
| FY2013 | Dec 31, 2013 | $186.86K | -81.7% |
| FY2012 | Dec 31, 2012 | $1.02M | -63.5% |
| FY2011 | Dec 31, 2011 | $2.79M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $180.21M | +2756.6% |
| Q2 FY2026 | Jun 30, 2026 | $196.33K | -93.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.69M | +41.9% |
| Q4 FY2025 | Dec 31, 2025 | $5.54M | +91.5% |
| Q3 FY2025 | Sep 30, 2025 | $6.31M | +13.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.90M | -67.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.19M | -74.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.89M | -57.9% |
| Q2 FY2024 | Jun 30, 2024 | $5.57M | -35.8% |
| Q1 FY2024 | Mar 31, 2024 | $8.92M | -17.0% |
| Q4 FY2023 | Dec 31, 2023 | $4.71M | -27.6% |
| Q3 FY2023 | Sep 30, 2023 | $6.86M | -24.2% |
| Q2 FY2023 | Jun 30, 2023 | $8.68M | -28.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.74M | -25.4% |
| Q4 FY2022 | Dec 31, 2022 | $6.50M | -60.6% |
| Q3 FY2022 | Sep 30, 2022 | $9.05M | -52.6% |
| Q2 FY2022 | Jun 30, 2022 | $12.06M | -42.1% |
| Q1 FY2022 | Mar 31, 2022 | $14.39M | -37.5% |
| Q4 FY2021 | Dec 31, 2021 | $16.50M | +7.0% |
| Q3 FY2021 | Sep 30, 2021 | $19.09M | +5767.1% |
| Q2 FY2021 | Jun 30, 2021 | $20.83M | +4502.0% |
| Q1 FY2021 | Mar 31, 2021 | $23.05M | +16099.6% |
| Q4 FY2020 | Dec 31, 2020 | $15.42M | +2129.3% |
| Q3 FY2020 | Sep 30, 2020 | $325.43K | -35.5% |
| Q2 FY2020 | Jun 30, 2020 | $452.65K | -37.3% |
| Q1 FY2020 | Mar 31, 2020 | $142.28K | -88.6% |
| Q4 FY2019 | Dec 31, 2019 | $691.54K | -60.3% |
| Q3 FY2019 | Sep 30, 2019 | $504.30K | -79.2% |
| Q2 FY2019 | Jun 30, 2019 | $721.99K | -74.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.25M | -29.7% |
| Q4 FY2018 | Dec 31, 2018 | $1.74M | -38.9% |
| Q3 FY2018 | Sep 30, 2018 | $2.42M | +133.7% |
| Q2 FY2018 | Jun 30, 2018 | $2.85M | +181.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.78M | +65.7% |
| Q4 FY2017 | Dec 31, 2017 | $2.85M | +42449.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.04M | +6855.6% |
| Q1 FY2017 | Mar 31, 2017 | $1.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.07M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.69K | – |
| Q2 FY2016 | Jun 30, 2016 | $14.91K | – |
See a number that looks wrong?